Enveric BiosciencesENVB
13F holders, Q2 2024 (June 30)17holders −1
4new positions
5sold out
$0.61avg. 13F price*
At the end of Q2 2024, 17 institutions reported holding Enveric Biosciences Inc. (ENVB) in their 13F filings, down 1 from Q1 2024. 4 opened new positions and 5 sold out. The largest holders were AdvisorShares Investments LLC ($190K), Geode Capital Management, LLC ($28K) and UBS Group AG ($27K).
- Company
- Enveric Biosciences Inc.
- CUSIP
- 29405E208
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $10K |
| Exits | 5 | $74K |
All 13F filers, Q1 2024 → Q2 2024: 164,239 shares bought and 146,948 shares sold, net +17,291 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| AdvisorShares Investments LLC | 0.03% | Add +32.8% | 317,047 | $190K |
| Geode Capital Management, LLC | 0.00% | Add +240.4% | 44,659 | $28K |
| UBS Group AG | 0.00% | Add +774.2% | 43,560 | $27K |
| BlackRock Inc. | 0.00% | No change | 29,578 | $19K |
| Vanguard Group Inc. | 0.00% | No change | 18,198 | $11K |
| Two Sigma Securities, LLC | 0.00% | New | 15,240 | $10K |
| Virtu Financial LLC | 0.00% | Reduce -59.2% | 13,792 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.7% | 11,455 | $7K |
| HRT Financial LP | 0.00% | Reduce -82.6% | 10,972 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +310.0% | 615 | $385 |
| Group One Trading LLC | 0.00% | No change | 273 | $169 |
| Bank of America Corp. | 0.00% | Add +64.0% | 164 | $103 |
| FMR LLC | 0.00% | New | 120 | $74 |
| National Bank of Canada | 0.00% | No change | 70 | $41 |
| Wells Fargo & Company | 0.00% | Reduce -56.8% | 16 | $10 |
| Mather Group, Llc. | 0.00% | New | 8 | $8 |
| ORG Partners LLC | 0.00% | New | 10 | $5 |
"% of holder's portfolio" is ENVB's weight in each manager's 13F, not the share of Enveric Biosciences Inc. the manager owns.